Works matching IS 09509232 AND DT 2008 AND VI 27 AND IP 23

Results: 14

MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease.
Published in:
Oncogene, 2008, v. 27, n. 23, p. 3274, doi. 10.1038/sj.onc.1210982
By:
- Szabova, L.;
- Chrysovergis, K.;
- Yamada, S. S.;
- Holmbeck, K.
Publication type:
Article
Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia.
Published in:
Oncogene, 2008, v. 27, n. 23, p. 3221, doi. 10.1038/sj.onc.1210984
By:
- Nakayama, T.;
- Hieshima, K.;
- Arao, T.;
- Jin, Z.;
- Nagakubo, D.;
- Shirakawa, A.-K.;
- Yamada, Y.;
- Fujii, M.;
- Oiso, N.;
- Kawada, A.;
- Nishio, K.;
- Yoshie, O.
Publication type:
Article
Orphan nuclear receptor estrogen-related receptor-β suppresses in vitro and in vivo growth of prostate cancer cells via p21WAF1/CIP1 induction and as a potential therapeutic target in prostate cancer.
Published in:
Oncogene, 2008, v. 27, n. 23, p. 3313, doi. 10.1038/sj.onc.1210986
By:
- Yu, S.;
- Wong, Y. C.;
- Wang, X. H.;
- Ling, M. T.;
- Ng, C. F.;
- Chen, S.;
- Chan, F. L.
Publication type:
Article
Retinoic acid downregulates Rae1 leading to APCCdh1 activation and neuroblastoma SH-SY5Y differentiation.
Published in:
Oncogene, 2008, v. 27, n. 23, p. 3339, doi. 10.1038/sj.onc.1210987
By:
- Cuende, J.;
- Moreno, S.;
- Bolaños, J. P.;
- Almeida, A.
Publication type:
Article
ZIP kinase plays a crucial role in androgen receptor-mediated transcription.
Published in:
Oncogene, 2008, v. 27, n. 23, p. 3292, doi. 10.1038/sj.onc.1210995
By:
- Leister, P.;
- Felten, A.;
- Chasan, A. I;
- Scheidtmann, K. H.
Publication type:
Article
Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
Published in:
Oncogene, 2008, v. 27, n. 23, p. 3233, doi. 10.1038/sj.onc.1210988
By:
- Laulajainen, M.;
- Muranen, T.;
- Carpén, O.;
- Grönholm, M.
Publication type:
Article
Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152.
Published in:
Oncogene, 2008, v. 27, n. 23, p. 3244, doi. 10.1038/sj.onc.1210990
By:
- Tao, Y.;
- Zhang, P.;
- Girdler, F.;
- Frascogna, V.;
- Castedo, M.;
- Bourhis, J.;
- Kroemer, G.;
- Deutsch, E.
Publication type:
Article
The EWS/FLI1 oncogenic transcription factor deregulates GLI1.
Published in:
Oncogene, 2008, v. 27, n. 23, p. 3282, doi. 10.1038/sj.onc.1210991
By:
- Zwerner, J. P.;
- Joo, J.;
- Warner, K. L.;
- Christensen, L.;
- Hu-Lieskovan, S.;
- Triche, T. J.;
- May, W. A.
Publication type:
Article
Ephrin-A1 promotes the malignant progression of intestinal tumors in Apcmin/+ mice.
Published in:
Oncogene, 2008, v. 27, n. 23, p. 3265, doi. 10.1038/sj.onc.1210992
By:
- Shi, L.;
- Itoh, F.;
- Itoh, S.;
- Takahashi, S.;
- Yamamoto, M.;
- Kato, M.
Publication type:
Article
Array painting reveals a high frequency of balanced translocations in breast cancer cell lines that break in cancer-relevant genes.
Published in:
Oncogene, 2008, v. 27, n. 23, p. 3345, doi. 10.1038/sj.onc.1210993
By:
- Howarth, K. D.;
- Blood, K. A.;
- Ng, B. L.;
- Beavis, J. C.;
- Chua, Y.;
- Cooke, S. L.;
- Raby, S.;
- Ichimura, K.;
- Collins, V. P.;
- Carter, N. P.;
- Edwards, P. A. W.
Publication type:
Article
Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study.
Published in:
Oncogene, 2008, v. 27, n. 23, p. 3256, doi. 10.1038/sj.onc.1210989
By:
- Tsantoulis, P. K.;
- Kotsinas, A.;
- Sfikakis, P. P.;
- Evangelou, K.;
- Sideridou, M.;
- Levy, B.;
- Mo, L.;
- Kittas, C.;
- Wu, X.-R.;
- Papavassiliou, A. G.;
- Gorgoulis, V. G.
Publication type:
Article
Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.
Published in:
Oncogene, 2008, v. 27, n. 23, p. 3329, doi. 10.1038/sj.onc.1210996
By:
- Nowacki, S.;
- Skowron, M.;
- Oberthuer, A.;
- Fagin, A.;
- Voth, H.;
- Brors, B.;
- Westermann, F.;
- Eggert, A.;
- Hero, B.;
- Berthold, F.;
- Fischer, M.
Publication type:
Article
Mutant B-RAF mediates resistance to anoikis via Bad and Bim.
Published in:
Oncogene, 2008, v. 27, n. 23, p. 3301, doi. 10.1038/sj.onc.1211003
By:
- Boisvert-Adamo, K.;
- Aplin, A. E.
Publication type:
Article
Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk.
Published in:
2008
By:
- Schwab, R.;
- Bussolari, R.;
- Corvetta, D.;
- Chayka, O.;
- Santilli, G.;
- Kwok, J. M.-M.;
- Ferrari-Amorotti, G.;
- Tonini, G. P.;
- Iacoviello, L.;
- Bertorelle, R.;
- Menin, C.;
- Hubank, M.;
- Calabretta, B.;
- Sala, A.
Publication type:
Correction Notice

Works matching IS 09509232 AND DT 2008 AND VI 27 AND IP 23

MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease.

Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia.

Orphan nuclear receptor estrogen-related receptor-β suppresses in vitro and in vivo growth of prostate cancer cells via p21<sup>WAF1/CIP1</sup> induction and as a potential therapeutic target in prostate cancer.

Retinoic acid downregulates Rae1 leading to APC<sup>Cdh1</sup> activation and neuroblastoma SH-SY5Y differentiation.

ZIP kinase plays a crucial role in androgen receptor-mediated transcription.

Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.

Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152.

The EWS/FLI1 oncogenic transcription factor deregulates GLI1.

Ephrin-A1 promotes the malignant progression of intestinal tumors in Apc<sup>min/+</sup> mice.

Array painting reveals a high frequency of balanced translocations in breast cancer cell lines that break in cancer-relevant genes.

Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study.

Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.

Mutant B-RAF mediates resistance to anoikis via Bad and Bim.

Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk.